Search results

  1. Simon M

    Development of surrogate end-point biomarkers for chronic fatigue and myalgic encephalmyelitis/chronic fatigue syndrome (ME/CFS)

    This has me slightly mystified, but looks like a large-scale replicatioin of the brain neuroinflammation study that caused such a stir back in 2014: First Direct Evidence of Neuroinflammation – ‘Encephalitis’ – in ME/CFS 120 is an enormous sample size for a PET study - a good thing but also...
  2. Simon M

    Open (MA, USA) “Brain Scan Study [PET-MR] of ME/CFS, 2023, VanElzakker

    This thread Suggests that the planned pilot study might be redundant because a much bigger study is in the pipeline: https://www.s4me.info/index.php?threads/development-of-surrogate-end-point-biomarkers-for-chronic-fatigue-and-myalgic-encephalmyelitis-chronic-fatigue-syndrome-me-cfs.965/ It...
  3. Simon M

    Physiological measures in participants with CFS, multiple sclerosis and healthy controls following repeated exercise, 2017, Hodges et al

    Well, certainly a very worthwhile approach but a pilot and only 7 mecfs and 7 MS patients makes the conclusion somewhat overblown I’m willing to bet they didn’t correct statistics appropriately for all the many comparisons, which might do for the stat sig results. Above all, we know that...
  4. Simon M

    What biomedical research progress in the past 18 months?

    Good question. In my view we only reached the start line for biomedical research a few years ago and there has been some structural progress since, attracting new researchers and a gradual increase in funding and interest, but certainly no breakthrough as yet. Which isn’t too bad in that...
  5. Simon M

    Articles on Montoya and Mark Davis's Cytokine work

    Briefly: Roerink et al argued that methodological issues with blood plasma processing could account for the finding of higher cytokine TGF-beta in patients. Montoya et al responded that they looked at blood serum, not plasma, as their paper had spelt out. Whatever the motivations behind the...
  6. Simon M

    Cellular bioenergetics is impaired in patients with CFS (2017) Tomas, Strassheim, Newton et al

    Nice post :) Do you know if she also presented data for B-cells and NK cells? What’s really interesting about this work is that her group are using Seahorse technology too, so should be directly comparable. The finding of using less of maximal respiratory capacity is potentially slightly...
  7. Simon M

    Cellular bioenergetics is impaired in patients with CFS (2017) Tomas, Strassheim, Newton et al

    The authors specifically said that was something they were considering.
  8. Simon M

    Cellular bioenergetics is impaired in patients with CFS (2017) Tomas, Strassheim, Newton et al

    The technology behind the new study finding (above) that cells from mecfs patients can't ramp up energy production Here's a bit more about the Seahorse technology and what it measures, using info from the Seahorse site. First off, it's looking at the body's two main energy pathways, glycolysis...
Back
Top Bottom